Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . May 10th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Drug Development - Murine hepatitis models can screen for Cav 1.3-specific therapy
Liver Cancer Therapy - Vesicular stomatitis virus infusions staunch hepatocellular carcinoma in rats
Microbiology - Autoimmune liver disease patients show evidence of Helicobacter infection
Oncogenesis - Hepatitis B virus preS1 sequences stimulate squamous cell carcinoma antigen
Oncogenesis - Specific hepatitis B virus mutations predict liver cancer formation
Adverse Drug Effects - Interferon-alpha stimulates optic neuropathy in a chronic hepatitis C patient
Antiphospholipid Syndrome - Features of HIV- and hepatitis C-related APS described
Cancer Biomarker - Squamous cell carcinoma antigen variants are overexpressed in liver cancer
Diagnostics - Home Access FDA-approved at-home tests to be distributed internationally
Diagnostics - Primovist, a new MRI liver-contrast agent, approved in Sweden
Diagnostics - Solid phase ELISA panels detect hepatitis B virus biomarkers in sera
Drug Development - N-terminally PEGylated interferon-beta yields improved pharmacology
Enzymology - Sphingomyelinase activity modulates the development of lethal hepatitis
Fatty Liver Disease - Antioxidant defense mechanisms stem non-alcoholic steatohepatitis progression
Finance - Claritin manufacturer posts $73 million first-quarter loss
HIV/AIDS - Effect of HIV infection on NK cell inhibitory receptors clarified
HIV/HBV Coinfection - Acute HIV infection linked to stable or reduced HBV loads
Hepatitis B - 1-year results announced for Telbivudine hepatitis B treatment candidate
Hepatitis B - Metabasis reports $1M milestone payment for remofovir
Hepatitis B - New combination therapy studied in hepatitis B clinical trial
Hepatitis B - New data support Hepsera's long-term efficacy against chronic hepatitis B
Hepatitis C - Study results highlight therapies for unmet needs in hepatitis C treatment
Hepatitis C Therapy - Interferon/ribavirin therapy can be safe, but sustained response remains low
Hepatology - Mechanical massage enhances liver cell gene transfer in the mouse
Liver Cirrhosis - Company announces positive results in bioavailability study for Icatibant
Psychology - Indoleamine 2,3-dioxygenase plays a role in interferon-alpha-induced depression
Safety Syringes - Safety syringes market continues to grow
Steatohepatitis - Oxidative stress rises with non-alcoholic fatty liver disease progression
Transplant Medicine - Bioartificial liver reduces mortality by 44% in acute liver-failure patients
Transplant Medicine - Researchers report a possible technique for expanding the donor liver pool
Vaccine Delivery - DNA virus-like particles elicit immune responses by oral administration
Viral Epidemiology - Andaman and Nicobar Islands tribal school children harbor HBV infections
Viral Genomics and Genetics - United States chickens have subclinical avian hepatitis E virus infections
Viral Proteomics - Hepatitis C virus core protein impedes cell cycle progression
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
